Irwin Naturals price target lowered to $3.00 from $4.50 at Roth MKM

Roth MKM lowered the firm’s price target on Irwin Naturals (IWINF) to $3.00 from $4.50 but keeps a Buy rating on the shares. The company’s Q2 results were softer than expected, with weakness coming from a high-selling product SKU loss at Costco (COST) and shuttering of nonprofitable clinics, while increased costs associated with the clinic integrations led to gross margins of 45%, below the firm’s 49% expectation, the analyst tells investors in a research note.